Immune analysis of on-treatment longitudinal biopsies predicts response to melanoma immunotherapy
Wednesday, August 10, 2016 - 23:01
in Health & Medicine
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers report.